# Lotus Lake Ventures

> Lotus Lake Ventures is a VC fund in Beijing backing Medical and Health Care. See 78 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Beijing, China
- Total investments: 78
- Last investment: Jul 2026
- Lead investor: 24%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/tuspark-ventures
- Website: http://tsinghua-vc.com/

Lotus Lake Ventures is an investment firm committed to investing in science and technology innovation enterprises, focusing on high-tech and high-tech enterprises with core competitiveness in the initial stage and growth stage..

## Contacts

5 contacts available for Lotus Lake Ventures. Shizune tracks 4 team members at Lotus Lake Ventures. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/lotus-lake-ventures?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $42k–$72M |
| Series A | $709k–$97M |
| Series B | $2M–$40M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 19 | 24% |
| Health Care | 19 | 24% |
| Biotechnology | 17 | 22% |
| Manufacturing | 12 | 15% |
| Pharmaceutical | 11 | 14% |

75 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 23 | 29% |
| Series B | 20 | 26% |
| Seed | 12 | 15% |
| Angel | 6 | 8% |
| Series C | 5 | 6% |

9 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 66 | 85% |
| India | 1 | 1% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Han Zhou | Managing Director | 1 | https://shizune.co/investors/profile/han-zhou-041a |
| Jun Xue | Founding Partner | 0 | https://shizune.co/investors/profile/jun-xue |
| Lin Lei | Founding Partner | 0 | https://shizune.co/investors/profile/lin-lei |
| Michael Chen | Associate | 0 | https://shizune.co/investors/profile/michael-chen-9 |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Torrey Pines Medicine | Torrey Pines Medicine is a biotechnology business focused on creating next-generation ultra-long-acting peptide therapies for metabolic illnesses. |  | Angel | Jul 28, 2026 |  |
| Fulinlan Technology | Fulinlan is committed to the planning, design, development, structural analysis, equipment processing and installation of non-standard proprietary equipment, precision parts and other products in the field of aerospace. |  | Seed | Jun 16, 2026 |  |
| Huanying Medical | Huanying Medical specializes in ultrasound technology and independently develops its core components. |  | Series B | Jun 15, 2026 |  |
| Zhongke Qingneng | Zhongke Qingneng is a green-tech company that specializes in the development and manufacturing of hydrogen liquefaction and cryogenic equipment. | $71.9M | Seed | Feb 01, 2026 |  |
| Luanqi Technology | Luanqi Technology is a storage product testing equipment R & D and sales company. | $14.3M | Series B | Jan 16, 2026 |  |
| Micro Interventional | Micro Interventional is a company that develops active interventional innovative medical devices. It emphasizes the development of novel medical devices with a product strategy centered on the precise interventional treatment of coronary heart disease and peripheral arterial disease. |  | Series A | Dec 16, 2025 |  |
| Reprogenix | Reprogenix is a groundbreaking medical technology firm that began with stem cell therapy for diabetes and is dedicated to expanding the use of cell therapy in a wide range of disease areas. | $70.3M | Series A | Nov 20, 2025 |  |
| Ronghe Medical | Ronghe Medical is a medical device manufacturer specializing in the design, research and development, production, and sales of high-end medical device systems based on advanced energy ablation technology platforms, delivering innovative therapeutic solutions that enhance clinical precision, improve patient outcomes, and support a wide range ofmedical applications. | $14.1M | Series B | Nov 18, 2025 |  |
| Null Hypothesis | Null Hypothesis is an AI medical SaaS company that focuses on the development of intelligent medical products using AIGC. | $14.1M |  | Oct 30, 2025 |  |
| Jinghe Semiconductor | Jinghe Semiconductor is a high-tech enterprise specializing in the research, development, and manufacturing of advanced equipment for semiconductor devices, providing cutting-edge solutions that support the production of integrated circuits, microchips, and other core components essential to the global electronics industry. |  | Seed | Oct 23, 2025 |  |

10 of 78 investments shown.

## Co-investors
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund, 4 deals together
- [Longmen Capital](https://shizune.co/investors/profile/longmen-capital) — VC Fund, 3 deals together
- [Northern Light Venture Capital](https://shizune.co/investors/profile/northern-light-venture-capital) — VC Fund, 3 deals together
- [Shanghai Yingbo Enterprise Development](https://shizune.co/investors/profile/shanghai-yingbo-enterprise-development-co-ltd) — VC Fund, 3 deals together
- [Shanghai Yingjieyu Investment Management](https://shizune.co/investors/profile/shanghai-yingjieyu-investment-management-co-ltd) — VC Fund, 3 deals together
- [THG Ventures](https://shizune.co/investors/profile/thg-ventures) — VC Fund, 3 deals together

## Similar investors

### Similar industry
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund
- [HSG](https://shizune.co/investors/profile/sequoia-capital-china) — VC Fund

## Featured in investor lists
- [Health Care Investors in China](https://shizune.co/investors/health-care-investors-china)
- [Health Care VC Funds in China](https://shizune.co/investors/health-care-vc-funds-china)
- [Health Care Investors in Asia](https://shizune.co/investors/health-care-investors-asia)
- [Health Care VC Funds in Asia](https://shizune.co/investors/health-care-vc-funds-asia)
- [Medical Investors in China](https://shizune.co/investors/medical-investors-china)
- [Medical VC Funds in China](https://shizune.co/investors/medical-vc-funds-china)

## FAQ

### What does Lotus Lake Ventures invest in?

Lotus Lake Ventures invests primarily in Medical, Health Care and Biotechnology startups, most often at Series A and Series B stage. Most of the 78 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Lotus Lake Ventures's check size?

Lotus Lake Ventures typically joins rounds of $42k–$72M at Seed, $709k–$97M at Series A and $2M–$40M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Lotus Lake Ventures participates in.

### How do I contact Lotus Lake Ventures?

Public channels for Lotus Lake Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Lotus Lake Ventures?

The team at Lotus Lake Ventures includes Han Zhou (Managing Director), Jun Xue (Founding Partner) and Lin Lei (Founding Partner). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co